Viral infection causes rapid sensitization to lipopolysaccharide: Central role of IFN-αβ

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 982-988

  Nansen, A ^a   Thomsen, A R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA,BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON INDUCING AGENT; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE TARGETING; HYPERSENSITIVITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

EID: 0035863865     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.982     Document Type: Article

References (47)

1. Septic shock: Pathogenesis
2. The role of IFN-γ in the pathology of experimental endotoxemia
3. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α
4. Mice lacking the tumour necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
5. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
6. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections
7. IFN-γ involvement in the severity of Gram-negative infections in mice
8. Role of interferon-γ in experimental Gram-negative sepsis
9. Interferon-γ receptor deficient mice are resistant to endotoxic shock
10. Macrophage activation by T cells: Cognate and non-cognate signals
11. Macrophage priming by interferon γ: A selective process with potentially harmful effects
12. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor
13. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
14. Interleukin-12, interferon-γ, and tumor necrosis factor-α are the key cytokines of the generalized Shwartzman reaction
15. γ-Interferon: The match that lights the fire?
16. Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo
17. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lippolysaccharides
18. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice
19. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: Role of T cell-dependent production of interferon-γ
20. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for NK and T cell IFN-γ production
21. Changes in hemopoiesis during the course of acute LCM virus infection in mice
22. Involvement of interferon in virus-induced lymphopenia
23. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses
24. Functional role of type I and type II interferons in antiviral defense
25. Influence of host genes on the outcome of murine lymphocytic choriomeningitis virus infection
26. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing
27. Exogenous interferon-γ induces endogenous synthesis of interferon-α and -β by murine macrophages for induction of nitric oxide synthase
28. Effect of interferon on thoracic duct lymphocyte output: Induction with either poly I: Poly C or vaccinia virus
29. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes
30. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice
31. In vivo anti-tumor activity of combinations of interferon-α and interleukin-2 in a routine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells
32. Inhibition of experimentally-induced murine metastases by recombinant α interferon: Correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases
33. Role of natural killer cells in virus infections of mice
34. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense: Studies of natural killer and T cell responses in contrasting viral infections
35. Viruses and T cell turnover: Evidence for bystander proliferation
36. + T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression
37. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells
38. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite
39. Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cells
40. Molecules and mechanisms operating in septic shock: Lessons from knockout mice
41. Tumor necrosis factor and the systemic inflammatory response syndrome
42. Role of macrophage cytokines in influenza A virus infections
43. Interferon-α prevents endotoxin-induced mortality in mice
44. Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity
45. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide
46. The neglected role of type I interferon in the T-cell response: Implications for its clinical use
47. The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis